QSS
VNDA icon

Quantitative Systematic Strategies’s Vanda Pharmaceuticals VNDA Stock Holding History

Quantitative Systematic Strategies’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-18,677
Closed -$150K – 533
2016
Q1 		$150K Sell
18,677
-12,486
-40% -$102K 0.06% 358
2015
Q4 		$301K Buy
+31,163
New +$311K 0.08% 767

Other funds holding VNDA

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Quantitative Systematic Strategies's VNDA Position: Q2 2016 in Review

Quantitative Systematic Strategies sold out of Vanda Pharmaceuticals (VNDA) in Q2 2016, closing a stake of 18,677 shares — an estimated $150K sold.

Quantitative Systematic Strategies first reported a position in VNDA in Q4 2015 and held it in 2 quarters. The position peaked at $301K in Q4 2015. 115 funds tracked by Wall St. Rank hold VNDA as of Q2 2016.

  • Quantitative Systematic Strategies reported no remaining Vanda Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 18,677 Vanda Pharmaceuticals shares in Q2 2016, an estimated $150K.
  • Quantitative Systematic Strategies first reported a position in Vanda Pharmaceuticals in Q4 2015 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Vanda Pharmaceuticals position peaked at $301K in Q4 2015.
  • 115 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2016.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2016, filed 28 Jul 2016.